Patel Vishal S, Thamboo Andrew, Quon Jennifer, Nayak Jayakar V, Hwang Peter H, Edwards Michael, Patel Zara M
Division of Rhinology, Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Palo Alto, California, USA.
Division of Pediatric Neurosurgery, Department of Neurosurgery, Stanford University School of Medicine, Palo Alto, California, USA.
World Neurosurg. 2017 Dec;108:6-14. doi: 10.1016/j.wneu.2017.08.058. Epub 2017 Aug 23.
Craniopharyngiomas have traditionally been treated via open transcranial approaches. More recently, endoscopic transsphenoidal approaches have been increasingly used; however, few case series exist in the pediatric population.
A retrospective review of patients (aged <18 years) undergoing endoscopic transsphenoidal resection of craniopharyngiomas between 1995 and 2016 was performed. Preoperative data included presenting symptoms, tumor size, location, and components. Postoperative outcomes included symptom resolution, visual outcomes, endocrine outcomes, disease recurrence, and major complications.
Sixteen pediatric patients with mean age of 11.0 years (range, 5-15 years) were included. The median follow-up time was 56.2 months. Mean maximal tumor diameter was 3.98 cm. Most of the tumors had suprasellar (93.8%) and intrasellar (68.8%) components. The gross total resection rate was 93.8%. The most common presenting symptoms were vision changes (81.3%) and increased intracranial pressure (56.3%). Most patients (66.7%) had their presenting symptoms resolved by their first postoperative visit. Vision improved or remained normal in 69.2% of patients. Postoperatively, new incidence of panhypopituitarism or diabetes insipidus developed in 63.6% and 46.7% of patients, respectively. New hypothalamic obesity developed in 28.6% of patients. The postoperative cerebrospinal fluid leak rate was 18.8%. One patient died of intraventricular hemorrhage postoperatively. The major complication rate was 12.5%. Disease recurrence occurred in 1 patient with gross total resection (6.3%).
Endoscopic transsphenoidal resection for craniopharyngiomas can achieve high rates of total resection with low rates of disease recurrence in larger tumors than previously described. However, hypothalamic-pituitary dysfunction and cerebrospinal fluid leak remain significant postoperative morbidities.
颅咽管瘤传统上通过开颅经颅手术治疗。最近,内镜经蝶窦手术的应用越来越多;然而,儿科患者的病例系列报道较少。
对1995年至2016年间接受内镜经蝶窦切除颅咽管瘤的18岁以下患者进行回顾性研究。术前数据包括临床表现、肿瘤大小、位置和成分。术后结果包括症状缓解、视力结果、内分泌结果、疾病复发和主要并发症。
纳入16例儿科患者,平均年龄11.0岁(范围5 - 15岁)。中位随访时间为56.2个月。平均最大肿瘤直径为3.98 cm。大多数肿瘤具有鞍上(93.8%)和鞍内(68.8%)成分。全切除率为93.8%。最常见的临床表现为视力改变(81.3%)和颅内压升高(56.3%)。大多数患者(66.7%)在术后首次就诊时症状得到缓解。69.2%的患者视力改善或保持正常。术后,分别有63.6%和46.7%的患者出现了垂体功能减退或尿崩症的新发病例。28.6%的患者出现了新的下丘脑性肥胖。术后脑脊液漏发生率为18.8%。1例患者术后死于脑室内出血。主要并发症发生率为12.5%。1例全切除患者出现疾病复发(6.3%)。
内镜经蝶窦切除颅咽管瘤在较大肿瘤中可实现高全切除率和低疾病复发率,优于以往报道。然而,下丘脑 - 垂体功能障碍和脑脊液漏仍是显著的术后并发症。